Compare CORT & ESTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | ESTC |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 9.9B |
| IPO Year | 2001 | 2018 |
| Metric | CORT | ESTC |
|---|---|---|
| Price | $81.34 | $97.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 30 |
| Target Price | ★ $141.00 | $111.74 |
| AVG Volume (30 Days) | 830.8K | ★ 1.7M |
| Earning Date | 11-03-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 429.81 |
| EPS | ★ 0.09 | N/A |
| Revenue | $761,407,000.00 | ★ $1,739,331,000.00 |
| Revenue This Year | $50.53 | $15.29 |
| Revenue Next Year | $46.23 | $14.70 |
| P/E Ratio | $954.56 | ★ N/A |
| Revenue Growth | 12.79 | ★ 17.26 |
| 52 Week Low | $28.66 | $42.05 |
| 52 Week High | $126.38 | $108.00 |
| Indicator | CORT | ESTC |
|---|---|---|
| Relative Strength Index (RSI) | 22.77 | 50.91 |
| Support Level | $77.38 | $81.85 |
| Resistance Level | $122.93 | $101.39 |
| Average True Range (ATR) | 5.84 | 4.54 |
| MACD | -3.55 | 0.10 |
| Stochastic Oscillator | 0.71 | 41.48 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Elastic is a software company that specializes in AI-search, observability, and security deployments. Its search division offers both traditional keyword search and vector search methods to enable more context-aware querying. The software has open-source origins but generates revenue through valuable add-ons, including simplified data orchestration and server scaling techniques.